拜瑞妥怎么吃？

(Rivaroxaban) is a new type of oral anticoagulant drug that can be used for the prevention and treatment of deep vein thrombosis. Its efficacy and effect have been confirmed by clinical experiments. Xarelto has a safe, effective, simple and intuitive anticoagulant effect. Therefore, clinically, Xarelto has gradually replaced warfarin as the anticoagulant drug of choice for venous thrombosis, atrial fibrillation, pulmonary embolism and other diseases. Today we will learn more about how to take Xarelto?

The recommended dose is oral Xarelto (rivaroxaban) 10 mg once daily. If the wound has stopped bleeding, the first medication should be administered between 6 and 10 hours after surgery. The length of treatment is determined by each patient's risk of VTE, i.e. by the type of orthopedic surgery the patient has undergone. For patients undergoing major hip surgery, a recommended course of treatment is 5 weeks. For patients undergoing major knee surgery, a recommended course of treatment is 2 weeks. If a dose is missed, the patient should take Xarelto immediately and continue taking the dose once daily the next day. Patients can take Xarelto with a meal or alone.

Treat DVT (venous thrombosis) and reduce the risk of acute DVT recurrence and PE: The recommended dose of Xarelto (rivaroxaban) for the initial treatment of acute DVT is 15 mg twice a day for the first three weeks, and then the dose for maintenance treatment and to reduce the risk of DVT recurrence and PE is 20 mg once a day.

Xarelto (rivaroxaban) was developed by Bayer in Germany. It is the world's first highly selective oral anticoagulant that directly inhibits factor It has been approved in many countries and has been successfully marketed by Bayer in more than 75 countries. In June 2009, Xarelto was officially launched in China under the trade name Xarelto. It is used to prevent or reduce the formation of blood clots, deep vein thrombosis (DVT) and pulmonary embolism (PE) after hip or knee replacement surgery.

Xarelto (rivaroxaban) has good efficacy mainly because Xarelto is a highly selective oral drug that directly inhibits factor Xa. By inhibiting factor Xarelto does not inhibit thrombin (activated factor II) and has no proven effect on platelets.

The above is the content of how to take Rivaroxaban. I hope it can help you!

Recommended related hot articles: /newsDetail/76614.html